ABEO · NASDAQ
Abeona Therapeutics (ABEO) Stock Price & Fundamentals
Abeona Therapeutics (ABEO) closed at $347.98 on Oct 9, 2026, up 0.52% from the previous close of $346.17.
Share price, past year
1Y +5.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $347.98 |
| Sep 30, 2026 | $340.19 |
| Aug 31, 2026 | $351.90 |
| Jul 31, 2026 | $352.04 |
| Jun 30, 2026 | $351.34 |
| May 29, 2026 | $353.03 |
| Apr 30, 2026 | $349.90 |
| Mar 31, 2026 | $363.08 |
| Feb 27, 2026 | $364.02 |
| Jan 30, 2026 | $350.65 |
| Dec 31, 2025 | $366.00 |
| Nov 28, 2025 | $338.58 |
| Oct 31, 2025 | $329.79 |
Key statistics
- Market cap
- $19.91B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$62.89M
- Shares outstanding
- 57.2M
- Dividend yield
- —
- 52-week range
- $322.60 – $375.35
Abeona Therapeutics's market cap is $19.91B, based on a share price of $347.98 and 57.2M shares outstanding as of Jun 30, 2026.
Financials
Abeona Therapeutics reported revenue of $5.82M for fiscal 2025.
Abeona Therapeutics earned net income of $71.18M in fiscal 2025, a net margin of 1,223.1%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.82M | +66.3% | $71.18M | 1,223.1% | $1.01 | −$84.30M |
| FY2023ended Dec 31, 2023 | $3.50M | +147.5% | −$54.19M | −1,548.2% | −$2.53 | −$37.34M |
| FY2022ended Dec 31, 2022 | $1.41M | −52.9% | −$39.70M | −2,807.4% | −$5.53 | −$43.61M |
| FY2021ended Dec 31, 2021 | $3.00M | −70.0% | −$84.94M | −2,831.2% | — | −$69.82M |
| FY2020ended Dec 31, 2020 | $10.00M | +233.6% | −$84.23M | −842.3% | — | −$36.36M |
| FY2018ended Dec 31, 2018 | $3.00M | +258.2% | −$56.67M | −1,890.3% | — | −$48.35M |
| FY2017ended Dec 31, 2017 | $837.00K | −5.9% | −$27.32M | −3,263.9% | — | −$23.52M |
| FY2016ended Dec 31, 2016 | $889.00K | −14.5% | −$21.87M | −2,460.4% | — | −$13.53M |
| FY2015ended Dec 31, 2015 | $1.04M | +12.4% | — | — | — | — |
| FY2014ended Dec 31, 2014 | $925.00K | — | — | — | −$15.26 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $11.38M | −$20.19M | −$0.35 |
| Q1 FY2026ended Mar 31, 2026 | $8.72M | −$17.08M | −$0.30 |
| Q2 FY2025ended Jun 30, 2025 | $400.00K | $108.83M | $1.71 |
| Q2 FY2023ended Jun 30, 2023 | $3.50M | — | — |
| Q2 FY2022ended Jun 30, 2022 | $1.00M | — | — |
| Q1 FY2022ended Mar 31, 2022 | $346.00K | — | — |
| Q3 FY2020ended Sep 30, 2020 | $7.00M | — | — |
| Q2 FY2019ended Jun 30, 2019 | $0.00 | — | — |
Company profile
- Name
- Abeona Therapeutics Inc.
- Ticker
- ABEO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 6555 Carnegie Ave, 4th Floor, Cleveland, OH 44103
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000318306
Recent SEC filings
- Sep 15, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jun 12, 2026
- Jun 12, 2026
- Jun 10, 2026
- Jun 4, 2026
- May 13, 2026
Frequently asked questions
What is Abeona Therapeutics's stock price?
Abeona Therapeutics (ABEO) closed at $347.98 on Oct 9, 2026, up 0.52% from the previous close of $346.17.
What is Abeona Therapeutics's market cap?
Abeona Therapeutics's market cap is $19.91B, based on a share price of $347.98 and 57.2M shares outstanding as of Jun 30, 2026.
How much revenue does Abeona Therapeutics make?
Abeona Therapeutics reported revenue of $5.82M for fiscal 2025.
Does Abeona Therapeutics pay a dividend?
Abeona Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Abeona Therapeutics Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures